Navigation Links
FDA Approves EDARBYCLOR (azilsartan medoxomil and chlorthalidone) for the Treatment of Hypertension
Date:12/20/2011

DEERFIELD, Ill. and OSAKA, Japan, Dec. 20, 2011 /PRNewswire/ -- Takeda Pharmaceutical Company Limited (Takeda) and its wholly-owned subsidiary, Takeda Pharmaceuticals North America, Inc., announced today that the U.S. Food and Drug Administration (FDA) approved EDARBYCLOR (azilsartan medoxomil and chlorthalidone) for the treatment of hypertension to lower blood pressure in adults. EDARBYCLOR is the only fixed-dose therapy in the U.S. to combine an angiotensin II receptor blocker (ARB) with the diuretic chlorthalidone in a once-daily, single tablet. The recommended starting dose of EDARBYCLOR is 40/12.5 mg and the maximum dose is 40/25 mg.

The two medications in EDARBYCLOR work to help lower blood pressure in patients with hypertension. Azilsartan medoxomil, marketed as EDARBI in the U.S., reduces blood pressure by blocking the action of angiotensin II, a vasopressor hormone that naturally exists within the body. When EDARBI blocks the angiotensin II receptor, blood vessels can stay relaxed and open, and blood pressure can be reduced. Chlorthalidone reduces the amount of water in the body by increasing the flow of urine, which helps to lower blood pressure. Prior landmark clinical outcomes trials have demonstrated that chlorthalidone is effective in reducing blood pressure in patients with hypertension and that long-term use is associated with reductions in serious hypertension-related complications.

"Hypertension is a complex disease that affects one in three Americans. It is critical to control hypertension because lowering blood pressure has been shown to reduce the risk of serious health consequences, including stroke and heart attack," said Domenic Sica, M.D., professor of internal medicine and nephrology at Virginia Commonwealth University Medical Center. "The approval of EDARBYCLOR provides an effective treatment option to lower blood pressure for appropriate patients with hypertension who may require a combination of drugs to help achieve b
'/>"/>

SOURCE Takeda Pharmaceuticals North America, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. FDA Approves Mechanical Cardiac Assist Device for Children With Heart Failure
2. FDA Approves Hologics Cervista High Throughput Automation System for Cervical Cancer Screening
3. FDA Approves First Generic Version of Cholesterol-Lowering Drug Lipitor
4. FDA Approves First Insomnia Drug for Middle-of-the-Night Waking Followed By Difficulty Returning to Sleep
5. FDA Approves Eylea for Eye Disorder in Older People
6. FDA Approves First Supplemental Test for Chagas Disease
7. FDA Approves Erwinaze to Treat a Form of Leukemia
8. FDA Approves New York Blood Centers HEMACORD™ for Stem Cell Transplantation
9. FDA Approves Erbitux to Treat Late-stage Head and Neck Cancer
10. FDA Approves Xarelto to Prevent Stroke in People With Common Type of Abnormal Heart Rhythm
11. FDA Approves U.S. Market Return for octagam® Following Octapharmas Implementation of Enhanced Safety Measures
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2015)... VALLEY FORGE, Pa. , June 2, 2015 /PRNewswire/ ... plans to  build three new distribution centers in ... MN ; and Newburgh, NY ... strengthening the company,s ability to improve product access, increase ... Today,s announcement is part of the company,s ongoing ...
(Date:6/2/2015)... DUBLIN , June 02, 2015 ... the addition of the "Electrophysiology Market by ... (Cryoablation, RF, Microwave), Lab Devices (Mapping, Recording, Generator, ... Global Forecasts to 2019" report to their ... is estimated to grow at a significant CAGR ...
(Date:6/2/2015)... June 2, 2015  Australian health technology company ... million to rapidly progress the company,s global ... (PKG™) mobile health technology. Foundation ... capital in the funding round. New investors ... net worth individuals and also the Israeli ...
Breaking Medicine Technology:AmerisourceBergen to Build Three New Distribution Centers 2Global Electrophysiology Market Report 2015-2019 - Product, Ablation Catheter, Lab Devices & Indication Analysis 2Global Electrophysiology Market Report 2015-2019 - Product, Ablation Catheter, Lab Devices & Indication Analysis 3Global Kinetics Corporation Closes AUD$14.8 Million Capital Raising 2Global Kinetics Corporation Closes AUD$14.8 Million Capital Raising 3
... 31, 2011 NewCardio, Inc., (OTC Bulletin Board: ... today that the Company has been invited to present ... at an upcoming conference entitled "Cardiovascular Safety in Drug ... Drug Administration (FDA), the Cardiac Safety Research Consortium (CSRC) ...
... March 31, 2011 The Breast Journal ... of image-guided needle biopsy of suspicious breast cancer lesions ... the Naviscan high-resolution breast PET scanner, otherwise known as ... alone has been able to target regions in the ...
Cached Medicine Technology:NewCardio Invited to Present Latest QTinno Performance Improvements at FDA-Sponsored Conference on Cardiovascular Safety in Drug Development 2NewCardio Invited to Present Latest QTinno Performance Improvements at FDA-Sponsored Conference on Cardiovascular Safety in Drug Development 3NewCardio Invited to Present Latest QTinno Performance Improvements at FDA-Sponsored Conference on Cardiovascular Safety in Drug Development 4NewCardio Invited to Present Latest QTinno Performance Improvements at FDA-Sponsored Conference on Cardiovascular Safety in Drug Development 5NewCardio Invited to Present Latest QTinno Performance Improvements at FDA-Sponsored Conference on Cardiovascular Safety in Drug Development 6Research on Crucial Role of PET-Guided Biopsy in Initial Breast Cancer Diagnosis and Presurgical Planning Published in The Breast Journal 2
(Date:6/2/2015)... Bitscape Infotech today announced it has ... Small and Midsized Cloud Solutions Award. The company was ... for demonstrating excellence in innovation and implementation of customer ... as no surprise to us as we feel our ... worldwide level by Microsoft. We will continue to lead ...
(Date:6/2/2015)... “ Radaris ” was featured on NewsWatch ... at the latest and coolest applications on the market for ... and technology expert, conducted the app review and shared with ... on a person. , According to Psychology Today, humans are ... to explain that curiosity is a part of human development. ...
(Date:6/2/2015)... TX, USA (PRWEB) June 02, 2015 ... microsystems, is deploying its growth strategy to benefit from ... BioMEMS: “In Yole Développement’s May 2015 Status of the ... will grow sharply and reach $6.6B in 2020,” says ... Yole Développement . , The analyst adds that ...
(Date:6/2/2015)... On October 1, 2015 the transition to ICD-10 will ... On Monday, June 1st Congressman Kevin Brady, chairman ... Means Committee, and 12 members of the Committee sent ... urging the administration to provide a smooth transition for ... the newest coding system for healthcare professionals to code ...
(Date:6/2/2015)... (PRWEB) June 02, 2015 Erbelli’s Gourmet ... website to promote its handmade gourmet pizzas and calzones, ... though the website is new, the recipes are not—they ... 1995. The main feature of the site is the ... pictures and descriptions of all the items. You can ...
Breaking Medicine News(10 mins):Health News:Bitscape Infotech recognized as finalist for 2015 Microsoft Worldwide small & midsized cloud solutions award. 2Health News:Bitscape Infotech recognized as finalist for 2015 Microsoft Worldwide small & midsized cloud solutions award. 3Health News:A Comprehensive People Search Application Was Featured on NewsWatch Television 2Health News:Tronics Aims to Benefit from Major Growth of Sensors and Related Technologies for Healthcare Applications 2Health News:HomeTown Health Launches a “100 Day Countdown” in Response to ICD-10 Survey 2Health News:HomeTown Health Launches a “100 Day Countdown” in Response to ICD-10 Survey 3Health News:HomeTown Health Launches a “100 Day Countdown” in Response to ICD-10 Survey 4Health News:Erbelli’s of Bradenton Launches New Mobile-Friendly Website 2
... The company behind Hello Kitty, the moon-faced cartoon cat turned ... worth 3.9 million yen (32,000 dollars) for the ultimate pampered ... 7,600 glass crystals and a cushion bearing Hello Kitty's face, ... later this month, Sanrio Co. said. ,Sanrio designer ...
... high-risk of having a heart attack are unclear about when ... an ambulance , argue a group of heart specialists in ... who die from coronary heart disease have had previous heart ... Foundation shows that 40% of the general population would not ...
... of heart disease gives a more accurate measure of how ... and which adults are most likely to benefit from treatment ... that in the general population without pre-existing cardiovascular disease or ... 75 in Britain at high risk of developing heart disease. ...
... exercise reduces inflammation a condition that is predictive of ... still not clear whether there is a definitive link. And ... is by no means fully understood. ,A recent ... of Illinois provides new evidence that may help explain some ...
... device company founded in 2004 to bring high performance ... markets, announced that vascular surgeons at the Krankenhaus Friedrichstadt ... their novel high performance vascular sealant, ArterX(TM). ... year old man suffering from vascular insufficiency of the ...
... response teams to combat diseases of all types in the ... formed to combat both contagious and non-contagious diseases in the ... health minister Ajay Vishnoi told IANS. ,He ... objective to compile survey work and immediate control of natural ...
Cached Medicine News:Health News:High-risk Patients Need Better Guidance on What is and Isnt a Heart Attack 2Health News:New Heart Disease Risk Score Will Help Minimise Health Inequalities 2Health News:New Heart Disease Risk Score Will Help Minimise Health Inequalities 3Health News:Exercise Reduces Inflammation 2Health News:Exercise Reduces Inflammation 3Health News:Exercise Reduces Inflammation 4Health News:Tenaxis Medical Inc. Announces First Human Use of Vascular Sealant 2
... leader in automatic slide stainers. It offers ... slide staining, ending messy procedures. The instrument ... marrow and other body fluids. With the ... a superb cytocentrifuge with eight-slide capacity and ...
Cholesterol, Total. An automated analyzer test kits....
For the quantitative determination of total cholesterol in human serum....
For the quantitative in vitro determination of lithium in serum and plasma. Wavelength: 550 nm. Linear range: up to 4 mm....
Medicine Products: